- Global Pharma News & Resources

Hypopharyngeal Cancer Treatment Market Trends in 2021, Industry Share, Size Analysis, Growth Insights, Opportunities, Business Forecast by 2026 | Exclusive Reportage by CMI

SEATTLE, April 08, 2021, (PHARMIWEB) — Global Hypopharyngeal Cancer Treatment Market

Hypopharyngeal cancer is the malignant tumor initiated in the cells of hypopharynx. Malignant cell of the hypopharyngeal cancer can metastasis into cervical lymph nodes, pharyngeal muscles, cranial nerves, larynx, thyroid, esophagus, lungs, liver or bone leading to secondary cancer. Hypopharyngeal cancer can be differentiated in the stages of cancer based on the size of the tumor. The early stages of hypopharyngeal cancer are asymptomatic whereas in late stages symptoms like sore throat, difficulty in swallowing, painful swallowing, weight loss or blood in mucus and saliva can be visible. Hypopharyngeal cancer can be diagnosed through X-ray, ultrasound, panendoscopy, biopsy, CT scan, MRI, PET scan or PET-CT scan. Treatment for hypopharyngeal cancer includes surgeries like transoral robotic surgery (TORS) and transoral videolaryngoscopic surgery or TOVS, chemotherapy and chemoradiotherapy, and targeted therapy. Researchers are also looking for more ways like transplantation and tissue grafting to rebuild cells post-surgery.

*The Download PDF brochure only consist of Table of Content, Research Framework, and Research Methodology.

Request PDF Research Report Brochure @

Global Hypopharyngeal Cancer Treatment Market Insights

Low survival rate of hypopharyngeal cancer is raising the demand of research and development in this field. According to the American Cancer Society in 2017, the estimated survival rate of this type of cancer is below average in comparison to other cancers, i.e., Stage I (53%), Stage II (39%), Stage III (36%) and Stage IV (24%) which is below 50%. Governmental organization are also sponsoring the research and development for cancer studies to bring better treatment for hypopharyngeal cancer treatment market and increase its survival rate. For instance, Dana-Farber Cancer Institute sponsored research study for drug BKM120 (buparlisib) for indication of hypopharyngeal cancer, in October, 2014. Such new drug trials will augment the growth of the global hypopharyngeal cancer treatment market.

For instance, the article published in journal Case Reports in Oncology in 2017, studied Nivolumab, a humanized IgG4 and programmed death 1 monoclonal antibody, demonstrated antitumor efficacy in clinical trials of various malignant tumors including squamous cell carcinomas of neck and head and non-small-cell lung cancer. Furthermore, increase in collaboration between companies and hospitals to study the efficacy of the candidate drug will also augment the overall market growth. For instance, in 2012, Biotech Pharmaceutical Co., Ltd. and the Second People’s Hospital collaborated to conduct a randomized, multicenter phase II study to compare the efficiency and safety of adding nimotuzumab to neoadjuvant and CCRT for the indication of Oropharyngeal Cancer and Hypopharyngeal Cancer.

Increasing incidence of hypopharyngeal cancer is expected to propel the growth of the global hypopharyngeal cancer treatment market. As per the statistical data compiled by the American Society of Clinical Oncology (ASCO), in 2016, every year 3000 peoples are diagnosed with hypopharyngeal cancer in the U.S. Surging rate of smoking tobacco and drinking alcohol, also lead to the hypopharyngeal cancer and in turn boost the growth of the hypopharyngeal cancer treatment market. Cancers of the oral cavity and hypopharynx were highly common in south-central Asian countries like India because of extreme consumption of tobacco, bidi, and betel, even in several North American and European countries like Hungary, Slovakia, Germany, and France. According to the American Cancer Society 2016, the global incidence of lip, oral cavity, and pharyngeal cancers of 529,500, corresponding to 3.8% of all cancer cases which is estimated to reach 62% to 856,000 cases by 2035 because of changes in demographics.

Global Hypopharyngeal Cancer Treatment Market – Regional Analysis

North America is expected to dominate the global hypopharyngeal cancer treatment market over the forecast period, owing to increasing research and developmental activities by locally present pharmaceutical companies. However, Asia Pacific is expected to be fastest growing hypopharyngeal cancer treatment market due to high incidence of hypopharyngeal cancer in the region. For example, According to Indian Council of Medical Research (ICMR) 2013, the incidence of hypopharyngeal cancer is relatively higher among males in India i.e. approximately 11% against 1% worldwide.

Quick Buy – Hypopharyngeal Cancer Treatment Market Research Report:

Global Hypopharyngeal Cancer Treatment Market – Key Competitors

The leading players operating in the global hypopharyngeal cancer treatment market are Sanofi, Akorn Inc., Antares Pharma Inc., and Medac Pharma Inc.

Market Taxonomy

By Drug,

  • Chemotherapy
    • Taxol
    • Taxtere
    • Methotrexate
  • Targeted Therapy

By Distribution Channel,

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website –


Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 08-Apr-2021